Saudi Arabia Infectious Disease Molecular Diagnostics Market Size & Outlook

The infectious disease molecular diagnostics market in Saudi Arabia is expected to reach a projected revenue of US$ 292.8 million by 2028. A compound annual growth rate of 4.4% is expected of Saudi Arabia infectious disease molecular diagnostics market from 2021 to 2028.
Revenue, 2020 (US$M)
$208.2
Forecast, 2028 (US$M)
$292.8
CAGR, 2021 - 2028
4.4%
Report Coverage
Saudi Arabia

Saudi Arabia infectious disease molecular diagnostics market, 2018-2028 (US$M)

Saudi

Saudi Arabia infectious disease molecular diagnostics market highlights

  • The Saudi Arabia infectious disease molecular diagnostics market generated a revenue of USD 208.2 million in 2020 and is expected to reach USD 292.8 million by 2028.
  • The Saudi Arabia market is expected to grow at a CAGR of 4.4% from 2021 to 2028.
  • In terms of segment, reagents was the largest revenue generating product in 2020.
  • Reagents is the most lucrative product segment registering the fastest growth during the forecast period.


Infectious disease molecular diagnostics market data book summary

Market revenue in 2020USD 208.2 million
Market revenue in 2028USD 292.8 million
Growth rate4.4% (CAGR from 2020 to 2028)
Largest segmentReagents
Fastest growing segmentReagents
Historical data2018 - 2019
Base year2020
Forecast period2021 - 2028
Quantitative unitsRevenue in USD million
Market segmentationInstruments, Reagents
Key market players worldwideAbbott Laboratories, Danaher Corp, BioMerieux SA, Roche Holding AG ADR, Bio-Rad Laboratories Inc, Agilent Technologies Inc, Becton Dickinson & Co, Hologic Inc, Illumina Inc, Grifols SA Ordinary Shares - Class A, Qiagen NV, Siemens Healthineers AG ADR, Sysmex Corp


Other key industry trends

  • In terms of revenue, Saudi Arabia accounted for 0.6% of the global infectious disease molecular diagnostics market in 2020.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2028.
  • In Middle East & Africa, UAE infectious disease molecular diagnostics market is projected to lead the regional market in terms of revenue in 2028.
  • South Africa is the fastest growing regional market in Middle East & Africa and is projected to reach USD 214.2 million by 2028.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Infectious Disease Molecular Diagnostics Market Companies

Name Profile # Employees HQ Website

Saudi Arabia infectious disease molecular diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to infectious disease molecular diagnostics market will help companies and investors design strategic landscapes.


Reagents was the largest segment with a revenue share of 66.23% in 2020. Horizon Databook has segmented the Saudi Arabia infectious disease molecular diagnostics market based on instruments, reagents covering the revenue growth of each sub-segment from 2018 to 2028.


The infectious diseases molecular diagnostics market in Saudi Arabia is likely to exhibit a CAGR of 4.4% during the forecast period. High unmet clinical needs, rise in disposable income, and increase in number of collaborative agreements with international organizations, such as WHO and United Nations, are creating opportunities for growth of infectious disease molecular diagnostics market in Saudi Arabia.

Moreover, increase in incidence of infectious diseases is expected to drive market growth. For instance, according to the WHO, in 2017, prevalence of hepatitis B in those above 5 years of age was 2.24% and estimated number of carriers was 636,000. 

However, as per a study by NCBI in 2019, only 14% of the cases are diagnosed in the region. This gap is creating an opportunity for molecular diagnostics. In addition, due to rising number of COVID-19 cases in the country, the government entered into a USD 264 million deal for COVID-19 tests with China in April 2020.

Reasons to subscribe to Saudi Arabia infectious disease molecular diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Saudi Arabia infectious disease molecular diagnostics market databook

  • Our clientele includes a mix of infectious disease molecular diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia infectious disease molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia infectious disease molecular diagnostics market from 2018 to 2028, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Saudi Arabia infectious disease molecular diagnostics market size, by product, 2018-2028 (US$M)

Saudi Arabia Infectious Disease Molecular Diagnostics Market Outlook Share, 2020 & 2028 (US$M)

Saudi Arabia infectious disease molecular diagnostics market size, by product, 2018-2028 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more